Table 1.
Family number | Family ID | Origin | Phenotype | Experimental procedure | Causative allele change | Nucleotide change | Number of affected family members analysed | Number of unaffected family members analysed | Total number of family members analysed |
---|---|---|---|---|---|---|---|---|---|
1 | GC1980614 | Latvian | NCMD | SNP, aCGH, WGS, PCR/Sanger | chr5:4391377–4436535 | 45158 bp duplication | 5 | 1 | 6 |
2 | GC1562611 | British | NCMD | SNP, aCGH, WGS, PCR/Sanger | chr5:4396927–4440442 | 43515 bp duplication | 9 | 8 | 17 |
3 | GC15119 | British | NCMD | SNP, aCGH, WGS, PCR/Sanger | chr5:4396927–4440442 | 43515 bp duplication | 4 | 0 | 4 |
4 | GC13840 | British | NCMD | SNP, WGS, PCR/Sanger | chr5:4396927–4440442 | 43515 bp duplication | 3 | 0 | 3 |
5 | GC19075 | British | NCMD | SNP, WGS, PCR/Sanger | chr5:4396927–4440442 | 43515 bp duplication | 3 | 0 | 3 |
6 | GC15475 | British | NCMD | SNP, WGS, PCR/Sanger | chr5:4396927–4440442 | 43515 bp duplication | 1 | 0 | 1 |
7 | GC11709 | British | NCMD | SNP, WGS, PCR/Sanger | chr5:4396927–4440442 | 43515 bp duplication | 1 | 0 | 1 |
8 | GC16913 | British | NCMD | PCR/Sanger | chr5:4396927–4440442 | 43515 bp duplication | 1 | 0 | 1 |
9 | GC4092 | British | NCMD | PCR/Sanger | chr5:4396927–4440442 | 43515 bp duplication | 1 | 0 | 1 |
10 | GC23501 | British | NCMD | PCR/Sanger | chr5:4396927–4440442 | 43515 bp duplication | 2 | 1 | 3 |
11 | GC15416 | British | NCMD | SNP, PCR/Sanger | chr6:100040987 | G > C (V2) | 2 | 0 | 2 |
12 | GC37227 | British | NCMD | SNP, PCR/Sanger | chr6:100040987 | G > C (V2) | 12 | 8 | 20 |
13 | GC172259, 15 | French | NCMD | SNP, PCR/Sanger | chr6:100040987 | G > C (V2) | 12 | 15 | 27 |
Total | 56 | 33 | 89 |
Genomic coordinates refer to GRCh37/hg19 assembly. SNP, aCGH, WGS, PCR/Sanger indicate Illumina SNP array, array-based comparative genomic hybridization, whole-genome sequencing and Sanger Sequencing, respectively. Five affected members from five additional NCMD families were also tested for the presence of previously reported SNVs V1-V315 and the two tandem duplications found in this study, but none of these affected individuals was found to carry any of the variants.